MADISON MARTINO: Open Payments
NPI 1689347569 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,652 in 154 payments from 21 companies in 2025. Trend: 2023 $1,232 · 2024 $1,774 · 2025 $2,652
Food & beverage: $2,583Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $529 |
| Galderma Laboratories, L.P. | 13 | $294 |
| Incyte Corporation | 10 | $269 |
| Regeneron Healthcare Solutions, Inc. | 9 | $254 |
| PFIZER INC. | 15 | $216 |
| Arcutis Biotherapeutics, Inc. | 16 | $195 |
| Amgen Inc. | 10 | $146 |
| UCB, Inc. | 8 | $134 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Organon LLC | 5 | $88 |
Products named: SKYRIZI, DUPIXENT, OPZELURA, NEMLUVIO, RINVOQ, CIBINQO, Zoryve, Otezla.
Industry payments across NJ — which companies pay providers there.
